Evening Market Wrap

U.S. equities ended Friday in the red, with the Nasdaq 100 leading declines at -1.50%, while the Dow Jones fell 0.77% and the S&P 500 dropped 0.99%. The broad retreat reflected ongoing pressure in technology and semiconductors, yet a remarkable rally in healthcare stocks and multiple earnings surprises revealed a market in selective rotation rather than wholesale capitulation.

Healthcare Outperformance Defies Broader Slump

The day's most striking feature was healthcare's resilience. Five of the top eight gainers hailed from the sector, with ORKA, DNTH, SION, and TRVI each climbing between 9-12%. Even as the Technology sector declined -1.14% and Industrials fell -0.81%, healthcare eked out a modest +0.22% gain. SLS surged 12.3% and LCID, the sole consumer cyclical outperformer, jumped 13.9%—suggesting targeted strength in high-conviction bets rather than broad market enthusiasm.

TRV (Financial Services) added 9.2% and VG (Energy) climbed 8.9%, signaling that rotation extended beyond healthcare into defensive and commodity-linked names.

Earnings Season Delivers, But Unevenly

Companies reporting Friday posted notable results. USAU delivered a stunning EPS beat of +203%, while PLD, UNH, and HOVR beat expectations by 51%, 31%, and 21% respectively. TSM and ISRG both exceeded profit forecasts—relevant given the semiconductor sector's weakness elsewhere—yet neither garnered the outsized gains of healthcare names. This disconnect suggests investors are cherry-picking winners rather than responding uniformly to earnings quality.

STT impressively beat both EPS (+9%) and revenue (+4%), signaling execution strength in financial services.

Analyst Sentiment Fractures on Tech Giants

The day's narrative became murkier when examining mega-cap positions. AAPL faced conflicting signals: UBS and HSBC downgraded the stock to Sell and Reduce respectively, yet Jefferies upgraded it to Buy—all near the $334 level. This analyst fragmentation reflects genuine uncertainty about the iPhone maker's near-term trajectory.

META, by contrast, moved in one direction: HSBC upgraded to Buy citing cloud infrastructure ambitions, including a potential $10B deal with Anthropic. The narrative shift toward enterprise computing proved compelling enough to overcome broader tech weakness.

What This Means

Today's action was not a capitulation but a reallocation. The persistent decline in semiconductors and broad tech—coupled with Netflix signaling subscriber growth deceleration—has triggered a hunt for earnings quality elsewhere. Healthcare's outperformance wasn't euphoric; it was methodical, suggesting institutional money rotating from high-valuation software and chips into defensive healthcare and financials.

The Russell 2000 fell only -0.52%, underperforming the Nasdaq but significantly outperforming on a relative basis, hinting at selective strength in domestic-focused equities and regional plays like CMC and CTBI, both showing multiple bullish signals.

Looking Ahead

Monday will test whether healthcare's gains hold or reverse. Watch for renewed semiconductor pressure—a headwind all week—and monitor whether the AAPL analyst divide resolves with fresh conviction. If Monday opens with continued healthcare resilience and stabilizing tech valuations, today's decline may mark a healthy pause rather than a bearish reversal.